The short answer: these three terms describe how much of the hemp plant's original cannabinoid and terpene profile is left in a product after extraction. Full spectrum keeps nearly everything, including trace THC. Broad spectrum is processed to remove THC while keeping other cannabinoids. Isolate is purified down to CBD alone. None of the three terms is defined in federal law, and peer-reviewed testing has found that a meaningful share of products don't match the category printed on their own label. The label name is a starting point, not a guarantee.
What “Full Spectrum,” “Broad Spectrum,” and “CBD Isolate” Are Meant to Describe
Industry convention — not a federal rule — generally uses the three terms this way:
- Full spectrum: Contains the broad range of cannabinoids, terpenes, and flavonoids naturally present in the hemp plant, including trace delta-9 THC. Under the 2018 Farm Bill, a hemp-derived product is meant to stay at or below 0.3% THC by dry weight to remain federally legal.
- Broad spectrum: Starts from a similar whole-plant extract but goes through additional processing intended to remove THC while keeping other cannabinoids and terpenes in place.
- CBD isolate: Purified down to cannabidiol alone, with other plant cannabinoids and terpenes removed. Isolate products are typically marketed at very high CBD purity.
Some marketers also reference an “entourage effect” — the idea that multiple cannabinoids and terpenes acting together produce a stronger effect than CBD alone. This remains a working theory under active research rather than an established clinical finding, and it should not be read as a guarantee of any specific outcome for an individual product or user.
Are These Terms Consistently Defined?
No. The 2018 Farm Bill defines “hemp” by its THC threshold, but it does not define “full spectrum,” “broad spectrum,” or “isolate” as labeling categories, and the FDA has not issued a regulation standardizing them either. That gap shows up in testing. A 2024 analysis in Frontiers in Pharmacology examined 202 commercially available CBD products — tinctures, gummies, vapes, and topicals — and checked each one's lab-tested cannabinoid profile against the “full spectrum,” “broad spectrum,” or “CBD isolate” claim printed on its packaging. Twenty-six percent of the tested products did not meet the definition of the category they claimed.
Without a binding federal standard, enforcement has started to move to the state level in a patchwork way; trade coverage has reported states such as New York writing their own regulatory definitions for these extract categories specifically because no uniform one existed. For a shopper, that means the same three words can mean something slightly different depending on which brand printed them.
Does “Broad Spectrum” Guarantee No THC Exposure?
No, and this is the gap most worth understanding before using a broad-spectrum or “THC-free” product for a reason that matters — a scheduled drug test, for example, or a decision to avoid THC entirely for personal or legal reasons.
A 2022 study in Drug and Alcohol Dependence tested 80 commercially available hemp-derived CBD products, purchased from both online and local retailers, against a regulated control (Epidiolex, the only CBD product with FDA drug approval). Delta-9 THC was detected above the assay's detection limit in 52 of the 80 products. Of the 21 products in that sample specifically labeled “THC-Free,” five still had detectable delta-9 THC, at concentrations the researchers reported ranging from roughly 0.015 to 0.656 mg/mL. The researchers concluded that consumers are often using these products without understanding the risk of unintentional THC exposure, which can carry consequences beyond health — including drug-test results that affect employment, military service, or sport eligibility.
Put plainly: “broad spectrum” describes a processing goal — removing THC — not a verified outcome on every bottle. A product can be labeled broad spectrum, or even THC-free, and still contain a measurable trace of THC if the extraction and testing weren't rigorous. The terms for one full-spectrum gummy product reviewed on this site illustrate the underlying problem from the label side: the seller's own sales materials described the product as full spectrum but did not publish a per-gummy CBD or THC amount, leaving a shopper to request that information directly rather than read it off the package.
What a Label Term Can't Tell You
A few limits are worth stating directly:
- A label term or a lab result does not establish efficacy or individual safety. It tells you what was measured in that batch, not what the product will do for a given person.
- The FDA has not approved any over-the-counter CBD product. The only FDA-approved CBD drug, Epidiolex, is a prescription medication for specific seizure disorders. The FDA has stated that CBD and THC are excluded from the legal definition of a dietary supplement, and that unapproved CBD products sold online or in stores have not been evaluated by the agency for safety, efficacy, correct dosing, or drug interactions.
- Cannabis use in general carries documented health considerations — effects on heart rate and blood pressure, interactions with driving-related skills, and risks tied to accidental ingestion by children, among others — that apply regardless of which extract category a product falls into.
- Anyone taking prescription medication, managing a health condition, pregnant or breastfeeding, or purchasing a product for a minor should raise the specific product and its lab documentation with a physician or pharmacist rather than relying on the spectrum label alone.
An Annotated Label Checklist
Because the category name on the front of a package isn't independently verified, the more useful habit is reading past it. Before relying on a “full spectrum,” “broad spectrum,” or “isolate” claim, check for:
- A Certificate of Analysis (COA) from an independent, third-party lab — not just a logo or QR code, but an actual batch-specific report.
- A batch or lot number on the product that matches the batch number on the COA you're looking at. A generic COA that doesn't tie to your specific bottle doesn't confirm anything about it.
- A stated milligram amount for THC, not just a category word. “Broad spectrum” or “THC-free” on its own is a marketing claim; a milligram figure (or “non-detect” at a stated detection limit) from the COA is a measurement.
- A stated milligram amount for CBD per serving, cross-checked against the COA rather than taken from the sales page alone — labeling studies have found meaningful gaps between claimed and measured CBD content as well as THC content.
- The testing date. A COA from years ago, or with no date at all, doesn't confirm what's in a current batch.
- Contaminant screening (heavy metals, pesticides, residual solvents) alongside cannabinoid content, since spectrum labeling and purity are tested separately and a product can pass one and fail the other.
None of this requires buying anything. A legitimate seller will provide a current, batch-matched COA on request; a seller who can't or won't is itself useful information.